181 related articles for article (PubMed ID: 37601809)
1.
Cervena K; Siskova A; Jungwirth J; Volarić M; Kral J; Kohout P; Levy M; Vymetalkova V
Int J Gen Med; 2023; 16():3517-3531. PubMed ID: 37601809
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions.
Siskova A; Kral J; Drabova J; Cervena K; Tomasova K; Jungwirth J; Hucl T; Kohout P; Summerova S; Vodickova L; Vodicka P; Vymetalkova V
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887000
[TBL] [Abstract][Full Text] [Related]
3. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
4. Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors.
Chaleshi V; Irani S; Alebouyeh M; Mirfakhraie R; Aghdaei HA
Oncol Lett; 2020 Jun; 19(6):3937-3949. PubMed ID: 32391102
[TBL] [Abstract][Full Text] [Related]
5. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.
Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR
Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex.
Ji Q; Zhang L; Liu X; Zhou L; Wang W; Han Z; Sui H; Tang Y; Wang Y; Liu N; Ren J; Hou F; Li Q
Br J Cancer; 2014 Aug; 111(4):736-48. PubMed ID: 25025966
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
9. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X
EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA MALAT1 and Colorectal Cancer: A Propensity Score Analysis of Two Prospective Cohorts.
Li H; Zhang Y; Liu Y; Qu Z; Liu Y; Qi J
Front Oncol; 2022; 12():824767. PubMed ID: 35558512
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
12. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
13. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
14. Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy.
Waldmann E; Kammerlander AA; Gessl I; Penz D; Majcher B; Hinterberger A; Bretthauer M; Trauner MH; Ferlitsch M
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1890-1898. PubMed ID: 33878471
[TBL] [Abstract][Full Text] [Related]
15. Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.
Pan Y; Zhang L; Zhang R; Han J; Qin W; Gu Y; Sha J; Xu X; Feng Y; Ren Z; Dai J; Huang B; Ren S; Gu J
Am J Cancer Res; 2021; 11(6):3002-3020. PubMed ID: 34249441
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker.
Cervena K; Vodenkova S; Vymetalkova V
Gene; 2022 Nov; 843():146791. PubMed ID: 35961438
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA
Yang Q; Zheng W; Shen Z; Huang G; Yang G
Genet Test Mol Biomarkers; 2020 May; 24(5):239-248. PubMed ID: 32349546
[No Abstract] [Full Text] [Related]
20. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.
He X; Hang D; Wu K; Nayor J; Drew DA; Giovannucci EL; Ogino S; Chan AT; Song M
Gastroenterology; 2020 Mar; 158(4):852-861.e4. PubMed ID: 31302144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
